| case report | Q2782326 |
| scholarly article | Q13442814 |
| P50 | author | Maria Teresa Cruz-Carreras | Q89621970 |
| P2093 | author name string | Carmen Gonzalez | |
| Patrick Chaftari | |||
| Nandita Guha-Thakurta | |||
| Anna Shamsnia | |||
| P2860 | cites work | Prevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexate | Q28250460 |
| Posterior reversible encephalopathy syndrome after intrathecal methotrexate infusion: a case report and literature update | Q31148175 | ||
| Methotrexate treatment protocols and the central nervous system: significant cure with significant neurotoxicity | Q31444671 | ||
| High-dose leucovorin as sole therapy for methotrexate toxicity | Q33328846 | ||
| Neurological complications of radiotherapy and chemotherapy | Q34479195 | ||
| Methotrexate induced leucoencephalopathy: A stroke mimic | Q37210427 | ||
| Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia. | Q37627699 | ||
| Review of dextromethorphan administration in 18 patients with subacute methotrexate central nervous system toxicity | Q38205310 | ||
| The double-edged sword: Neurotoxicity of chemotherapy | Q38274890 | ||
| A biochemical perspective of methotrexate neurotoxicity with insight on nonfolate rescue modalities | Q41350492 | ||
| Aminophylline for methotrexate-induced neurotoxicity | Q42279602 | ||
| Demyelination and single-carbon transfer pathway metabolites during the treatment of acute lymphoblastic leukemia: CSF studies | Q42543252 | ||
| Dextromethorphan is effective in the treatment of subacute methotrexate neurotoxicity | Q44037900 | ||
| Neurotoxicity of intrathecal methotrexate: MR imaging findings | Q44619288 | ||
| Transient white matter changes on MR images in children undergoing chemotherapy for acute lymphocytic leukemia: correlation with neuropsychologic deficiencies | Q44736906 | ||
| Methotrexate-induced leukoencephalopathy reversed by aminophylline and high-dose folinic acid | Q44903483 | ||
| Reversible acute methotrexate leukoencephalopathy: atypical brain MR imaging features | Q46862458 | ||
| Methotrexate-induced acute toxic leukoencephalopathy | Q48425384 | ||
| Transient neurologic disturbances in a child treated with moderate-dose methotrexate | Q48463356 | ||
| A Stroke Mimic: Methotrexate-induced Neurotoxicity in the Emergency Department. | Q50950172 | ||
| Release of neuroactive substances: homocysteic acid as an endogenous agonist of the NMDA receptor | Q60491716 | ||
| The effects of leucovorin (folinic acid) on methotrexate therapy in rheumatoid arthritis patients | Q68095810 | ||
| High-dose methotrexate improves clinical outcome in children with acute lymphoblastic leukemia: St. Jude Total Therapy Study X | Q70222859 | ||
| Paraplegia following intrathecal chemotherapy neuropathologic findings and elevation of myelin basic protein | Q72667322 | ||
| Elevation of homocysteine and excitatory amino acid neurotransmitters in the CSF of children who receive methotrexate for the treatment of cancer | Q73585170 | ||
| Efficacy of early treatment of severe juvenile dermatomyositis with intravenous methylprednisolone and methotrexate | Q73737313 | ||
| Transient leukoencephalopathy after intrathecal methotrexate mimicking stroke | Q83226246 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 1644-1648 | |
| P577 | publication date | 2017-08-29 | |
| P1433 | published in | Clinical case reports | Q27725160 |
| P1476 | title | Methotrexate-induced leukoencephalopathy presenting as stroke in the emergency department | |
| P478 | volume | 5 |
Search more.